| CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes BA Schroeder, NA LaFranzo, BJ LaFleur, RM Gittelman, M Vignali, ... Journal for immunotherapy of cancer 9 (8), 2021 | 27 | 2021 |
| Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells PH Goff, L Riolobos, BJ LaFleur, MB Spraker, YD Seo, KS Smythe, ... Clinical Cancer Research 28 (8), 1701-1711, 2022 | 24 | 2022 |
| Immune modeling analysis reveals immunologic signatures associated with improved outcomes in high grade serous ovarian cancer NE James, K Miller, N LaFranzo, E Lips, M Woodman, J Ou, JR Ribeiro Frontiers in oncology 11, 622182, 2021 | 18 | 2021 |
| Arsonic Acid Self‐Assembled Monolayers Protect Oxide Surfaces from Micronewton Nanomechanical Forces NA LaFranzo, JA Maurer Advanced Functional Materials 23 (19), 2415-2421, 2013 | 11 | 2013 |
| Creating two-dimensional patterned substrates for protein and cell confinement DM Johnson, NA LaFranzo, JA Maurer JoVE (Journal of Visualized Experiments), e3164, 2011 | 7 | 2011 |
| Predictive immune modeling of solid tumors NA LaFranzo, KC Flanagan, D Quintanilha JoVE (Journal of Visualized Experiments), e60645, 2020 | 6 | 2020 |
| Sequence or structure: using bioinformatics and homology modeling to understand functional relationships in cAMP/cGMP binding domains NA LaFranzo, MK Strulson, DM Yanker, LT Dang, JA Maurer Molecular BioSystems 6 (5), 894-901, 2010 | 5 | 2010 |
| Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma KC Flanagan, J Earls, I Schillebeeckx, J Hiken, RL Wellinghoff, ... Journal of cancer research and clinical oncology 149 (15), 14125-14136, 2023 | 4 | 2023 |
| A Multidimensional Gene Expression Model that Accurately Predicts Tumor Response to Pembrolizumab or Nivolumab D Adkins, J Ley, N LaFranzo, J Hiken, I Schillebeeckx, P Oppelt, K Palka, ... International Journal of Radiation Oncology, Biology, Physics 106 (5), 1132-1133, 2020 | 3 | 2020 |
| Matters of Ethics NA LaFranzo, N Giordano, E Arriaga Addressing Gender Bias in Science & Technology, 127-144, 2020 | 2 | 2020 |
| Connecting younger chemists N LaFranzo Chemical & Engineering News 95 (34), 35-35, 2017 | 2 | 2017 |
| Multidimensional gene expression models for characterizing response and metastasis in solid tumor samples WP Carney, M Bhagat, N LaFranzo Proceedings of the American Association for Cancer Research Annual Meeting, 2019 | 1 | 2019 |
| Can we stop calling them nontraditional careers? NA LaFranzo Chemical and Engineering News 96 (32), 2018 | 1 | 2018 |
| Use of Self-Assembled Monolayers to Tailor Surface Properties: From Lubrication to Neuronal Development NA LaFranzo Washington University in St. Louis, 2013 | 1 | 2013 |
| Strategic portfolio optimization and innovation within ACS NA LaFranzo CHEMICAL & ENGINEERING NEWS 100 (8), 27-27, 2022 | | 2022 |
| Natalie A. LaFranzo NA LaFranzo CHEMICAL & ENGINEERING NEWS 99 (33), 40-41, 2021 | | 2021 |
| Moving Beyond a Static Roadmap for Diagnostics NA LaFranzo Journal of Precision Medicine| Volume 7 (1), 2021 | | 2021 |
| A single-center retrospective study of the immune landscape in patients with untreated liposarcoma (LS) with long-term follow-up BA Schroeder, NA LaFranzo, BJ LaFleur, KC Flanagan, RM Gittelman, ... Cancer Research 80 (16_Supplement), 3864-3864, 2020 | | 2020 |
| Immune biomarkers in the tumor microenvironment associated with response in pre-treatment non-small cell lung cancer (NSCLC) samples with second line immunotherapy follow-up data M Bhagat, WH Kim, L Memeo, L Colarossi, N LaFranzo, S Daniel, ... Cancer Research 80 (16), 2020 | | 2020 |
| Predictive Immune Modeling enables biomarker discovery in NSCLC patients treated with second line immunotherapy N LaFranzo, S Daniel, W Carney, M Bhagat, N LaFranzo JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
